Cui L, Kwong J, Wang CC. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis. J Ovarian Res. 2015;8:38.

Article  PubMed  PubMed Central  Google Scholar 

Risson E, Nobre AR, Maguer-Satta V, Aguirre-Ghiso JA. The current paradigm and challenges ahead for the dormancy of disseminated tumor cells. Nat Cancer. 2020;1:672–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Materna V, Liedert B, Thomale J, Lage H. Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells. Int J Cancer. 2005;115:393–402.

Article  CAS  PubMed  Google Scholar 

Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53:615–27.

Article  CAS  PubMed  Google Scholar 

Sun S, Cai J, Yang Q, Zhu Y, Zhao S, Wang Z. Prognostic value and implication for chemotherapy treatment of ABCB1 in epithelial ovarian cancer: a meta-analysis. PLoS One. 2016;11:e0166058.

Article  PubMed  PubMed Central  Google Scholar 

Wang JQ, Wu ZX, Yang Y, Teng QX, Li YD, Lei ZN, Jani KA, Kaushal N, Chen ZS. ATP-binding cassette (ABC) transporters in cancer: a review of recent updates. J Evid Based Med. 2021;14:232–56.

Article  PubMed  Google Scholar 

Jang SH, Wientjes MG, Au JL. Kinetics of P-glycoprotein-mediated efflux of paclitaxel. J Pharmacol Exp Ther. 2001;298:1236–42.

CAS  PubMed  Google Scholar 

Stordal B, Hamon M, McEneaney V, Roche S, Gillet JP, O’Leary JJ, Gottesman M, Clynes M. Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein. PLoS One. 2012;7:e40717.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, Schlag PM. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15:59–67.

Article  CAS  PubMed  Google Scholar 

Dahlmann M, Werner R, Kortum B, Kobelt D, Walther W, Stein U. Restoring treatment response in colorectal cancer cells by targeting MACC1-Dependent ABCB1 expression in combination therapy. Front Oncol. 2020;10:599.

Article  PubMed  PubMed Central  Google Scholar 

Zhang R, Shi H, Ren F, Li X, Zhang M, Feng W, Jia Y. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. Oncol Rep. 2016;35:2466–72.

Article  CAS  PubMed  Google Scholar 

Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, Schlag PM. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One. 2012;7:e49249.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashktorab H, Hermann P, Nouraie M, Shokrani B, Lee E, Haidary T, Brim H, Stein U. Increased MACC1 levels in tissues and blood identify colon adenoma patients at high risk. J Transl Med. 2016;14:215.

Article  PubMed  PubMed Central  Google Scholar 

Kortum B, Radhakrishnan H, Zincke F, Sachse C, Burock S, Keilholz U, Dahlmann M, Walther W, Dittmar G, Kobelt D, Stein U. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-beta-catenin-S100A4 axis of metastasis. Oncogene. 2022;41:4446–58.

Article  PubMed  PubMed Central  Google Scholar 

Link T, Kuhlmann JD, Kobelt D, Herrmann P, Vassileva YD, Kramer M, Frank K, Gockenjan M, Wimberger P, Stein U. Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer. Mol Oncol. 2019;13:1268–79.

Article  CAS  PubMed  PubMed Central  Google Scholar